Dendritic Cells in Cancer Immunotherapy Clinical Trials: Are We Making Progress?

por Butterfield, Lisa H.
Publicado 2013

Cancer vaccines

por Butterfield, Lisa H
Publicado 2015

Immunotherapy of hepatocellular carcinoma: Unique challenges and clinical opportunities

por Pardee, Angela D., Butterfield, Lisa H.
Publicado 2012

Dendritic Cell Control of Immune Responses

por Morel, Penelope A., Butterfield, Lisa H.
Publicado 2015

Alpha fetoprotein directly induces a unique pro-inflammatory, IL-2 hyperresponsive phenotype in human natural killer cells

por Vujanovic, Lazar, Stahl, Elizabeth, Butterfield, Lisa H
Publicado 2014

Dendritic Cell-Based Vaccines Positively Impact Natural Killer and Regulatory T Cells in Hepatocellular Carcinoma Patients

por Bray, Sarah M., Vujanovic, Lazar, Butterfield, Lisa H.
Publicado 2011

Cellular immunity induced by a recombinant adenovirus- human dendritic cell vaccine for melanoma

por Naveh, Hadas Prag, Vujanovic, Lazar, Butterfield, Lisa H
Publicado 2013

Tumor-derived alpha-fetoprotein impairs the differentiation and T cell stimulatory activity of human dendritic cells

por Pardee, Angela D, Shi, Jian, Butterfield, Lisa H
Publicado 2014

Multiplex serum biomarker assessments: technical and biostatistical issues

por Butterfield, Lisa H, Potter, Douglas M, Kirkwood, John M
Publicado 2011

Transduction of human dendritic cells with adenovirus encoding anti-PD-1 reduces PD-1 expression on co-cultured T cells

por Patricia, Santos, Alexander, Etheridge, Gambotto, Andrea, Butterfield, Lisa H
Publicado 2014

Improving the therapeutic index in adoptive cell therapy: key factors that impact efficacy

por Wang, Ena, Cesano, Alessandra, Butterfield, Lisa H, Marincola, Francesco
Publicado 2020

Alpha fetoprotein DNA prime and adenovirus boost immunization of two hepatocellular cancer patients

por Butterfield, Lisa H, Economou, James S, Gamblin, T Clark, Geller, David A
Publicado 2014

Tumor-derived alpha-fetoprotein (tAFP) causes immune and metabolic dysfunction in monocyte-derived dendritic cells

por Santos, Patricia M, Pardee, Angela, Delgoffe, Greg M, Butterfield, Lisa H
Publicado 2015

Highlights of the 31st annual meeting of the Society for Immunotherapy of Cancer (SITC), 2016

por Gulley, James L., Repasky, Elizabeth A., Wood, Laura S., Butterfield, Lisa H.
Publicado 2017

Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Immisch et al

por Chheda, Zinal S, Mueller, Sabine, Hegde, Bindu, Yamamichi, Akane, Butterfield, Lisa H, Okada, Hideho
Publicado 2023

Adenovirus-engineered human dendritic cells induce natural killer cell chemotaxis via CXCL8/IL-8 and CXCL10/IP-10

por Vujanovic, Lazar, Ballard, Wenners, Thorne, Stephen H., Vujanovic, Nikola L., Butterfield, Lisa H.
Publicado 2012

Tumor-derived alpha fetoprotein directly impacts human natural killer cell activity and viability

por Vujanovic, Lazar, Stahl, Elizabeth, Pardee, Angela, Watkins, Simon, Gibson, Gregory, Butterfield, Lisa H
Publicado 2015

Leptin in Children with Newly Diagnosed Type 1 Diabetes: Effect of Insulin Therapy

por McCormick, Kenneth L., Mick, Gail J., Butterfield, Lisa, Ross, Hugh, Parton, Elaine, Totka, Joan
Publicado 2001

Immuno-Oncology biomarkers 2010 and beyond: Perspectives from the iSBTc/SITC biomarker task force

por Butterfield, Lisa H, Disis, Mary L, Khleif, Samir N, Balwit, James M, Marincola, Francesco M
Publicado 2010

Preamble to the 2015 SITC immunotherapy biomarkers taskforce

por Butterfield, Lisa H, Disis, Mary L, Fox, Bernard A, Khleif, Samir N, Marincola, Francesco M
Publicado 2015